John A Scarlett - Net Worth and Insider Trading
John A Scarlett Net Worth
The estimated net worth of John A Scarlett is at least $0 dollars as of 2024-05-02. John A Scarlett is the Chairman, President and CEO of Geron Corp and owns about 0 shares of Geron Corp (GERN) stock worth over $0. Details can be seen in John A Scarlett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John A Scarlett has not made any transactions after 2023-02-10 and currently still holds the listed stock(s).
Transaction Summary of John A Scarlett
John A Scarlett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John A Scarlett owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , Chiasma Inc (CHMA) , and Geron Corp (GERN) .
Click here to see the complete history of John A Scarlett’s form 4 insider trades.
Insider Ownership Summary of John A Scarlett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-06-13 | director |
| CHMA | Chiasma Inc | 2020-06-11 | director |
| GERN | Geron Corp | 2023-02-10 | director & Chief Executive Officer |
John A Scarlett Latest Holdings Summary
John A Scarlett currently owns a total of 1 stock. John A Scarlett owns 0 shares of Geron Corp (GERN) as of February 10, 2023, with a value of $0.
Latest Holdings of John A Scarlett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GERN | Geron Corp | 2023-02-10 | 0 | 4.08 | 0 |
Holding Weightings of John A Scarlett
John A Scarlett Form 4 Trading Tracker
According to the SEC Form 4 filings, John A Scarlett has made a total of 1 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Geron Corp is the sale of 1,340,000 shares on February 10, 2023, which brought John A Scarlett around $4 Million.
Insider Trading History of John A Scarlett
- 1
John A Scarlett Trading Performance
GuruFocus tracks the stock performance after each of John A Scarlett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Scarlett is 33.65%. GuruFocus also compares John A Scarlett's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Scarlett within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John A Scarlett's insider trading performs compared to the benchmark.
Performance of John A Scarlett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.92 | | | | | |
| Relative Return to S&P 500(%) | 0.61 | | | | | |
John A Scarlett Ownership Network
John A Scarlett Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
John A Scarlett is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, John A Scarlett made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
John A Scarlett Mailing Address
Above is the net worth, insider trading, and ownership report for John A Scarlett. You might contact John A Scarlett via mailing address: C/o Geron Corporation, 230 Constitution Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
